The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance
Abstract
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases (IBDs) occurring in the gut of genetically susceptible individuals independent of a specific pathogen. The interaction between antigen-presenting cells and the local bacterial flora contributes to an uncontrolled activation of mucosal CD4+ T lymphocytes with the consecutive release of proinflammatory cytokines such as tumor necrosis factor (TNF), interleukin (IL)-6, IL-12, IL-23, IL-27, and also IL-17, which is attributed to a specific, differentiated CD4+ lineage called Th17 (TH-IL17, THi). Recent data suggest that IL-6 contributes to Th17 differentiation. However, to clarify the importance of Th17 cells in IBD further data are needed. So far, CD has been attributed to a Th1-mediated disease, whereas UC exhibits a modified Th2 cytokine response. In both diseases CD4+ T cells at the site of inflammation are critically dependent on antiapoptotic IL-6 signaling. Thereby, IL-6 induces the transcription factor STAT-3 via transsignaling (activation of a cell lacking membrane-bound IL-6 receptor via soluble IL-6 receptor). STAT-3 itself induces the antiapoptotic factors bcl-2 and bcl-xL, thus resulting in T-cell resistance against apoptosis. This vicious circle of T-cell accumulation, mediated by apoptosis resistance, finally leading to chronic inflammation, can be blocked by anti-IL-6 receptor antibodies. This review highlights the role of IL-6 in IBD immunopathogenesis and its clinical relevance in IBD therapy and diagnostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationRole of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Self-citationHirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K. H., & Kishimoto, T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5490 · Cited by 677
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616
IL-23 plays a key role in Helicobacter hepaticus –induced T cell–dependent colitis
Kullberg, M. C., Jankovic, D., Feng, C. G., Hue, S., Gorelick, P. L., McKenzie, B. S., Cua, D. J., Powrie, F., Cheever, A. W., Maloy, K. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061082 · Cited by 590
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584
The soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Shanahan, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07284-7 · Cited by 478
IL-6 is required for the development of Th1 cell-mediated murine colitis
Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411
Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Taga, T., Kishimoto, T., et al. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1461 · Cited by 409
Yokota, S., Miyamae, T., Imagawa, T., Iwata, N., Katakura, S., Mori, M., Woo, P., Nishimoto, N., Yoshizaki, K., & Kishimoto, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20944 · Cited by 370
B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.
Takai, Y., Wong, G. G., Clark, S. C., Burakoff, S. J., & Herrmann, S. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.2.508 · Cited by 366
Straub, R. H., Konecná, L., Hrach, S., Rothe, G., Kreutz, M. P., Schölmerich, J., Falk, W., & Lang, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2012 · Cited by 353
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation
McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., & Jones, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501794102 · Cited by 333
Fuss, I. J., Becker, C., Yang, Z., Groden, C., Hornung, R. L., Heller, F., Neurath, M. F., Strober, W., & Mannon, P. J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194183.92671.b6 · Cited by 326
Self-citationModulation of osteoclast differentiation by local factors
Suda, T., Udagawa, N., Nakamura, I., Miyaura, C., & Takahashi, N. (1995) · Bone · doi:10.1016/8756-3282(95)00185-g · Cited by 321
Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Kenney, J. S., Baumann, R., Poindron, P., & Duclos, B. (1996) · Gut · doi:10.1136/gut.39.5.684 · Cited by 297
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis
Peters, M., Müller, A. M., & Rose-John, S. (1998) · Blood · doi:10.1182/blood.v92.10.3495 · Cited by 276
Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer
Becker, C., Fantini, M. C., Wirtz, S., Nikolaev, A., Lehr, H. A., Galle, P. R., John, R., & Neurath, M. F. (2005) · Cell Cycle · doi:10.4161/cc.4.2.1413 · Cited by 255
Self-citationReview: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose-John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251
IL-6 Induces NF-κB Activation in the Intestinal Epithelia
Wang, L., Walia, B., Evans, J., Gewirtz, A. T., Merlin, D., & Sitaraman, S. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3194 · Cited by 243
Upregulation of Interleukin-12 and -17 in Active Inflammatory Bowel Disease
Nielsen, O. H., Kirman, I., Rüdiger, N., Hendel, J., & Vainer, B. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000672 · Cited by 240
De Benedetti, F., Massa, M., Pignatti, P., Albani, S., Novick, D., & Martini, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117206 · Cited by 234
(2012) · Hepatogastroenterology · doi:10.5754/hge10106 · Cited by 226
Moschen, A. R., Kaser, A., Enrich, B., Ludwiczek, O., Gabriel, M., Obrist, P., Wolf, A. M., & Tilg, H. (2005) · Gut · doi:10.1136/gut.2004.044370 · Cited by 226
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
Kallen, K.-J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00325-7 · Cited by 205
Black, K., Garrett, I. R., & Mundy, G. R. (1991) · Endocrinology · doi:10.1210/endo-128-5-2657 · Cited by 199
C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., & Fuller, G. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.599 · Cited by 196
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Neurath, M. F., Finotto, S., Fuss, I., Boirivant, M., Galle, P. R., & Strober, W. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01798-1 · Cited by 174
Self-citationHirotani, T., Lee, P. Y., Kuwata, H., Yamamoto, M., Matsumoto, M., Kawase, I., Akira, S., & Takeda, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3650 · Cited by 167
Hokama, A., Mizoguchi, E., Sugimoto, K., Shimomura, Y., Tanaka, Y., Yoshida, M., Rietdijk, S. T., de Jong, Y. P., Snapper, S. B., Terhorst, C., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.009 · Cited by 161
Kusugami, K., Fukatsu, A., Tanimoto, M., Shinoda, M., Haruta, J.-I., Kuroiwa, A., Ina, K., Kanayama, K., Ando, T., Matsuura, T., et al. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064182 · Cited by 151
Reinisch, W., Gasché, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhör, T., Bakos, S., Vogelsang, H., et al. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01288.x · Cited by 150
Hyams, J. S., Fitzgerald, J. E., Treem, W. R., Wyzga, N., & Kreutzer, D. L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90336-b · Cited by 146
Salmi, M., & Jalkanen, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4650 · Cited by 137
MacDonald, T. T. (2003) · Parasite Immunology · doi:10.1046/j.1365-3024.2003.00632.x · Cited by 126
Sawczenko, A., Azooz, O. G., Paraszczuk, J., Ideström, M., Croft, N. M., Savage, M. O., Ballinger, A., & Sanderson, I. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503589102 · Cited by 123
Daig, R., Rogler, G., Aschenbrenner, E., Vogl, D., Falk, W., Gross, V., Schölmerich, J., & Andus, T. (2000) · Gut · doi:10.1136/gut.46.3.350 · Cited by 104
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn??s disease
Louis, E. J., Bélaïche, J., Kemseke, C. V., Franchimont, D. P., Groote, D. D., Gueenen, V., & Mary, J. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199710000-00004 · Cited by 101
Rose‐John, S., & Neurath, M. F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00003-2 · Cited by 100
Self-citationReduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice
Naito, Y., Takagi, T., Uchiyama, K., Kuroda, M., Kokura, S., Ichikawa, H., Yanagisawa, R., Inoue, K.-I., Takano, H., Satoh, M., et al. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.2.191 · Cited by 92
IL6 and the acute phase reaction
Gauldie, J., Richards, C. D., & Baumann, H. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80018-g · Cited by 80
Kemseke, C. V., Bélaïche, J., & Louis, E. J. (2000) · International Journal of Colorectal Disease · doi:10.1007/s003840000226 · Cited by 72
Ito, H. (2003) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010033484296 · Cited by 65
Holtkamp, W., Stollberg, T., & Reis, H. E. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199503000-00010 · Cited by 65
Treatment of Crohn’s disease with anti-IL-6 receptor antibody
Ito, H. (2005) · Journal of Gastroenterology · doi:10.1007/bf02990576 · Cited by 62
Mudter, J., Wirtz, S. J., Galle, P. R., & Neurath, M. F. (2002) · Pathobiology · doi:10.1159/000068150 · Cited by 60
Self-citationBrown, K. A., Back, S. J., Ruchelli, E. D., Markowitz, J. E., Mascarenhas, M. R., Verma, R., Piccoli, D. A., & Baldassano, R. N. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06030.x · Cited by 54
Andus, T., Klebl, F. H., Rogler, G., Bregenzer, N., Schölmerich, J., & Straub, R. H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01433.x · Cited by 52
Hermann, E., Fleischer, B., Mayet, W.-J., Poralla, T., & Büschenfelde, K. ‐. M. Z. (1989) · PubMed · Cited by 50
Kai, Y., Takahashi, I., Ishikawa, H., Hiroi, T., Mizushima, T., Matsuda, C., Kishi, D., Hamada, H., Tamagawa, H., Ito, T., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.013 · Cited by 46
Ito, H., Hirotani, T., Yamamoto, M., Ogawa, H., & Kishimoto, T. (2002) · Journal of Gastroenterology · doi:10.1007/bf03326415 · Cited by 42
Suzuki, Y., Saito, H., Kasanuki, J., Kishimoto, T., Tamura, Y., & Yoshida, S. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90149-l · Cited by 42
Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis
Kitamura, K., Nakamoto, Y., Kaneko, S., & Mukaida, N. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604328 · Cited by 34
A Multifunctional Cytokine (IL-6/BSF-2) and Its Receptor
Hirano, T., Taga, T., Yamasaki, K., Matsuda, T., Tang, B., Muraguchi, A., Horii, Y., Suematsu, S., Hirata, Y., Yawata, H., et al. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234743 · Cited by 32
Polgar, A. A., Brózik, M., Tóth, S., et al. (2001) · PubMed · Cited by 28
Puzzling Out the Pains in the Gut
Marx, J. L. (2007) · Science · doi:10.1126/science.315.5808.33 · Cited by 19
Cawston, T. E., Curry, V. A., Ramsey, S., et al. (1995) · PubMed · Cited by 10
Cited by
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 576
Self-citationChitin nanofibers: preparations, modifications, and applications
Ifuku, S., & Saimoto, H. (2012) · Nanoscale · doi:10.1039/c2nr30383c · Cited by 490
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
Self-citationAliyu, M., Zohora, F. T., Anka, A. U., Ali, K., Maleknia, S., Saffarioun, M., & Azizi, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109130 · Cited by 401
Li, Y., de Haar, C., Chen, M., Deuring, J., Gerrits, M. M., Smits, R., Xia, B., Kuipers, E. J., & van der Woude, C. J. (2010) · Gut · doi:10.1136/gut.2009.184176 · Cited by 339
Metadata
- Authors
- Mudter, J., & Neurath, M. F.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08
- Volume
- 13
- Issue
- 8
- Pages
- 1016-1023
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2033286476
- Cited by
- 436
- References
- 73
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.